Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose
SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …
recommended in Canada and the United States, a second dose of pertussis vaccine during …
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …
Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States
Abstract Background In the United States, persons≥ 11 years are recommended to receive
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …
[HTML][HTML] Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria …
D Brandon, M Kimmel, SO Kuriyakose, L Kostanyan… - Vaccine, 2018 - Elsevier
Background Over the last decades, pertussis showed periodic increases in its incidence
among adults, despite being a vaccine-preventable disease. Methods This phase III …
among adults, despite being a vaccine-preventable disease. Methods This phase III …
Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …
SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …
vaccine is recommended in many countries for boosting immunity in adolescents and adults …
Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake
DM Skowronski, K Pielak, VP Remple, BA Halperin… - Vaccine, 2004 - Elsevier
BACKGROUND:: Lifetime protection against pertussis has been adopted as a goal of
immunization programs in Canada. To anticipate adult coverage with a combined product …
immunization programs in Canada. To anticipate adult coverage with a combined product …
Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
W Weston, M Messier, LR Friedland, X Wu, B Howe - Vaccine, 2011 - Elsevier
The duration of protection after vaccination with reduced antigen content diphtheria, tetanus
and acellular pertussis vaccines (Tdap) is not known. Long-term post-vaccination …
and acellular pertussis vaccines (Tdap) is not known. Long-term post-vaccination …
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …
M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …
increasing number of outbreaks have been observed over the last decades. The reduced …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …